Albemarle Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
$ALB
Major Chemicals
Industrials
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM 8-K
_________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2026
_________________________________
(Exact name of registrant as specified in charter)
_________________________________
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (980 ) 299-5700
Not applicable
(Former name or former address, if changed since last report.)
_________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
| Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) Effective as of February 26, 2026, the Board of Directors (the “Board”) of Albemarle Corporation (the “Company”) appointed Ms. Michelle T. Collins and Mr. Mark R. Widmar as independent members of the Board.
Ms. Collins has been appointed to the Board’s Audit & Finance Committee and Governance & Public Policy Committee. Mr. Widmar has been appointed to the Board’s Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee.
In accordance with our non-employee director compensation program, Ms. Collins and Mr. Widmar will each receive an annual retainer of $120,000, payable quarterly and pro-rated for partial quarter of appointment, and an annual grant of restricted stock equal to $170,000 at the grant date, rounded up to the nearest 25-share increment and pro-rated for partial year of appointment.
There is no arrangement or understanding with or between either of Ms. Collins or Mr. Widmar and any other persons pursuant to which they were selected as a director. There are no transactions in which either Ms. Collins or Mr. Widmar has an interest requiring disclosure under Item 404(a) of Regulation S-K.
Item 7.01 Regulation FD Disclosure.
On March 2, 2026, the Company issued a press release announcing the appointments, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 and in Exhibit 99.1 hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall either be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific references in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | Exhibit | ||||
| 99.1 | |||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALBEMARLE CORPORATION | |||||||||||
| Date: March 4, 2026 | By: | /s/ Ander C. Krupa | |||||||||
| Ander C. Krupa | |||||||||||
| General Counsel and Corporate Secretary | |||||||||||